Are higher myeloperoxidase levels an indicator of increased oxidative inflammatory activity?

Myeloperoxidase (MPO) is a heme-containing enzyme that serves as a pivotal mediator of the innate immune response. Predominantly stored within the azurophilic granules of neutrophils, its presence in systemic circulation is a recognized indicator of immune activation and oxidative stress.

Mechanistic release and function

The presence of MPO in the extracellular environment is a direct consequence of neutrophil activation. This release occurs through several well-characterized pathways:

• Degranulation and NETosis: Upon stimulation by pathogens or inflammatory signals, neutrophils release MPO into the extracellular space via classical degranulation. Additionally, during NETosis, MPO is released as part of Neutrophil Extracellular Traps (NETs), where it facilitates chromatin decondensation.
• Oxidative Burst: MPO utilizes hydrogen peroxide and chloride ions to catalyze the formation of hypochlorous acid (HOCl). While HOCl is essential for killing ingested microbes, it is also a potent reactive oxygen species (ROS) that can cause significant collateral damage to host tissues.

Clinical evidence of inflammatory activity

Elevated levels of MPO are consistently linked to heightened oxidative and inflammatory states across various clinical populations:

• Biomarker of Oxidative Stress: Research demonstrates that MPO levels correlate strongly with Total Oxidant Status (TOS) and the Oxidative Stress Index (OSI). Its enzymatic activity is a primary driver of lipid peroxidation and protein modification, making it a validated marker for oxidative damage in conditions such as cardiovascular disease, diabetes, and COPD.
• Correlation with Systemic Inflammation: Clinical studies show that plasma MPO levels reflect the inflammatory burden and often mirror other markers like high-sensitivity C-reactive protein (hsCRP). In cardiovascular contexts, elevated MPO is a prognostic indicator for adverse events, including myocardial infarction and cardiac death, as it reflects the extent of neutrophilic infiltration and plaque instability.
• Diagnostic Utility: While monocytes and some macrophages produce MPO, neutrophils remain the primary source during acute and chronic inflammation. Its measurement provides a specific look at neutrophil-mediated pathways that standard inflammatory markers may not fully capture.

Bottom line

The claim is strongly supported by scientific evidence. Myeloperoxidase is a primary enzyme of activated neutrophils, and its elevation directly indicates increased oxidative inflammatory activity through the production of potent reactive oxygen species and its role in systemic inflammatory signaling.